EGFR & ALK Inhibitors for Mutated Lung Cancer Tumors
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Objectives
NA
Target Audience
NA
Faculty & Disclosure
Faculty
Miguel A. Villalona-Calero, MD, FACP, FAAAS
Disclosure
Miguel A. Villalona-Calero, MD, FACP, FAAAS discloses no such relationships exist
Accreditation
NA
-1773064915543.webp&w=3840&q=75)
-1773064818174.webp&w=3840&q=75)